207 related articles for article (PubMed ID: 25853383)
1. Pelvic Exenteration in Gynecologic Cancer: La Paz University Hospital Experience.
Moreno-Palacios E; Diestro MD; De Santiago J; Hernández A; Zapardiel I
Int J Gynecol Cancer; 2015 Jul; 25(6):1109-14. PubMed ID: 25853383
[TBL] [Abstract][Full Text] [Related]
2. Pelvic exenterations for gynecological malignancies: a study of 36 cases.
Kaur M; Joniau S; D'Hoore A; Van Calster B; Van Limbergen E; Leunen K; Penninckx F; Van Poppel H; Amant F; Vergote I
Int J Gynecol Cancer; 2012 Jun; 22(5):889-96. PubMed ID: 22617477
[TBL] [Abstract][Full Text] [Related]
3. Pelvic exenteration for recurrent squamous cell carcinoma of the pelvic organs arising from the cloaca--a single institution's experience over 16 years.
Tan KK; Pal S; Lee PJ; Rodwell L; Solomon MJ
Colorectal Dis; 2013; 15(10):1227-31. PubMed ID: 23714581
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of gynecologic oncology patients in King Chulalongkorn Memorial Hospital - complications and outcome of pelvic exenteration.
Oranratanaphan S; Termrungruanglert W; Sirisabya N
Asian Pac J Cancer Prev; 2013; 14(4):2529-32. PubMed ID: 23725169
[TBL] [Abstract][Full Text] [Related]
5. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA.
Berek JS; Howe C; Lagasse LD; Hacker NF
Gynecol Oncol; 2005 Oct; 99(1):153-9. PubMed ID: 16054678
[TBL] [Abstract][Full Text] [Related]
6. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
Jäger L; Nilsson PJ; Rådestad AF
Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
[TBL] [Abstract][Full Text] [Related]
7. Pelvic exenteration. Has it a role in 1987? A six year experience.
Shepherd JH
Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
[TBL] [Abstract][Full Text] [Related]
8. Surgical results of pelvic exenteration in the treatment of gynecologic cancer.
Petruzziello A; Kondo W; Hatschback SB; Guerreiro JA; Filho FP; Vendrame C; Luz M; Ribeiro R
World J Surg Oncol; 2014 Sep; 12():279. PubMed ID: 25200866
[TBL] [Abstract][Full Text] [Related]
9. Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.
Straubhar AM; Chi AJ; Zhou QC; Iasonos A; Filippova OT; Leitao MM; Awowole IO; Abu-Rustum NR; Broach VA; Jewell EL; Sandhu JS; Sonoda Y
Gynecol Oncol; 2021 Nov; 163(2):294-298. PubMed ID: 34518053
[TBL] [Abstract][Full Text] [Related]
10. Pelvic exenteration for gynecologic malignancies: Postoperative complications and oncologic outcomes.
Romeo A; Gonzalez MI; Jaunarena J; Zubieta ME; Favre G; Tejerizo JC
Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):121-125. PubMed ID: 28911880
[TBL] [Abstract][Full Text] [Related]
11. Total pelvic exenteration for primary and recurrent malignancies.
Ferenschild FT; Vermaas M; Verhoef C; Ansink AC; Kirkels WJ; Eggermont AM; de Wilt JH
World J Surg; 2009 Jul; 33(7):1502-8. PubMed ID: 19421811
[TBL] [Abstract][Full Text] [Related]
12. Trends and current aspects of reconstructive surgery for gynecological cancers.
Loverro M; Aloisi A; Tortorella L; Aletti GD; Kumar A
Int J Gynecol Cancer; 2024 Mar; 34(3):426-435. PubMed ID: 38438169
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of adjuvant chemotherapy after pelvic exenteration for gynecologic malignancies.
Andikyan V; Khoury-Collado F; Sandadi S; Tew WP; O'Cearbhaill RE; Konner JA; Sonoda Y; Barakat RR; Chi DS; Abu-Rustum NR
Int J Gynecol Cancer; 2013 Jun; 23(5):923-8. PubMed ID: 23698798
[TBL] [Abstract][Full Text] [Related]
14. Pelvic exenteration for gynecologic malignancies: The experience of a tertiary center from Greece.
Haidopoulos D; Pergialiotis V; Aggelou K; Thomakos N; Alexakis N; Stamatakis E; Rodolakis A
Surg Oncol; 2022 Mar; 40():101702. PubMed ID: 35065392
[TBL] [Abstract][Full Text] [Related]
15. [Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases].
Zhang Z; Zang R; Chen J
Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):288-90. PubMed ID: 11775910
[TBL] [Abstract][Full Text] [Related]
16. Predictors for long-term survival after interdisciplinary salvage surgery for advanced or recurrent gynecologic cancers.
Fleisch MC; Pantke P; Beckmann MW; Schnuerch HG; Ackermann R; Grimm MO; Bender HG; Dall P
J Surg Oncol; 2007 May; 95(6):476-84. PubMed ID: 17192947
[TBL] [Abstract][Full Text] [Related]
17. [Laparoscopy-assisted vaginal pelvic exenteration].
Ferron G; Querleu D; Martel P; Chopin N; Soulié M
Gynecol Obstet Fertil; 2006 Dec; 34(12):1131-6. PubMed ID: 17134933
[TBL] [Abstract][Full Text] [Related]
18. A modern-day experience with Brunschwig's operation: Outcomes associated with pelvic exenteration.
Rios-Doria E; Filippova OT; Straubhar AM; Chi A; Awowole I; Sandhu J; Broach V; Mueller JJ; Gardner GJ; Jewell EL; Zivanovic O; Leitao MM; Long Roche K; Abu-Rustum NR; Sonoda Y
Gynecol Oncol; 2022 Nov; 167(2):277-282. PubMed ID: 36064678
[TBL] [Abstract][Full Text] [Related]
19. Comparison of postoperative complications and quality of life between patients undergoing continent versus non-continent urinary diversion after pelvic exenteration for gynecologic malignancies.
Angeles MA; Mallet E; Rouanet P; Cabarrou B; Méeus P; Lambaudie E; Foucher F; Narducci F; Loaec C; Gouy S; Guyon F; Marchal F; Gladieff L; Martínez-Gómez C; Migliorelli F; Martinez A; Ferron G
Int J Gynecol Cancer; 2020 Feb; 30(2):233-240. PubMed ID: 31796531
[TBL] [Abstract][Full Text] [Related]
20. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
